Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
130.01
+5.83 (4.69%)
At close: Apr 17, 2026, 4:00 PM EDT
130.01
0.00 (0.00%)
After-hours: Apr 17, 2026, 4:40 PM EDT
Palvella Therapeutics Employees
Palvella Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 15 or 107.14% compared to the previous year.
Employees
29
Change (1Y)
15
Growth (1Y)
107.14%
Revenue / Employee
n/a
Profits / Employee
-$1,438,448
Market Cap
1.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 15 | 107.14% |
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Galapagos NV | 558 |
| Vericel | 398 |
| Intellia Therapeutics | 377 |
| Ocular Therapeutix | 325 |
| Nurix Therapeutics | 317 |
| Innoviva | 159 |
| Pharvaris | 129 |
| AnaptysBio | 104 |
PVLA News
- 4 days ago - Palvella Therapeutics Appoints John D. Doux, M.D. - GlobeNewsWire
- 10 days ago - Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales - GlobeNewsWire
- 17 days ago - Palvella Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 18 days ago - Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations - GlobeNewsWire
- 21 days ago - Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 24 days ago - Palvella Therapeutics to Host Full Year 2025 Financial Results Conference Call and Provide a Corporate Update on March 31, 2026 - GlobeNewsWire
- 25 days ago - Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services - GlobeNewsWire
- 4 weeks ago - Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin - GlobeNewsWire